|本期目录/Table of Contents|

[1]王跃华,张荣生,李增才,等.护固莱士和泰绫应用于精准肝切除创面的对比研究[J].医学研究与战创伤救治(原医学研究生学报),2016,18(02):135-137.[doi:10.3969/j.issn.1672-271X.2016.02.008]
 ANG Yue-hua,ZHANG Rong-sheng,LI Zeng-cai,et al.Comparison of home-made absorbable hemostatic agents on cutting surface of hepatectomy[J].JOURNAL OF MEDICALRESEARCH —COMBAT TRAUMA CARE,2016,18(02):135-137.[doi:10.3969/j.issn.1672-271X.2016.02.008]
点击复制

护固莱士和泰绫应用于精准肝切除创面的对比研究()

《医学研究与战创伤救治》(原医学研究生学报)[ISSN:1672-271X/CN:32-1713/R]

卷:
第18卷
期数:
2016年02期
页码:
135-137
栏目:
出版日期:
2016-04-09

文章信息/Info

Title:
Comparison of home-made absorbable hemostatic agents on cutting surface of hepatectomy
作者:
王跃华1张荣生2李增才2张斌2王轩2江涛2
1. 210002 江苏南京,南京军区联勤部门诊部;2. 210002 江苏南京,解放军81医院全军肿瘤中心肿瘤外科
Author(s):
ANG Yue-hua1 ZHANG Rong-sheng2 LI Zeng-cai2 ZHANG Bin2 WANG Xuan2 JIANG Tao2.
1.Outpatient Clinic, Health Department, Department of Joint Logistics,Nanjing Military Command, Nanjing, Jiangsu 210002, China; 2.Department of Surgery,Cancer Center of PLA,81 Hospital of PLA,Nanjing, Jiangsu 210002, China
关键词:
精准肝切除护固莱士泰绫
Keywords:
precision liver resection surgery fibringlue tistat
分类号:
R657.3
DOI:
10.3969/j.issn.1672-271X.2016.02.008
文献标志码:
A
摘要:
目的 比较护固莱士和泰绫应用于肝创面止血的临床疗效。方法 选取2013年9月-2014年10月某院因肝脏良、恶性肿瘤行精准肝切除术60例,随机分为护固莱士组、 泰绫组、对照组。观察术后腹腔引流液、引流液血红蛋白浓度、胆红素浓度及肝功能等指标。结果 三组年龄、性别、Child评分、病理类型、肿瘤大小、手术时间、出血量、手术 创面面积等差异无统计学意义(P>0.05)。术后三组患者肝功能恢复无明显差异(P>0.05)。使用护固莱士和泰绫处理手术创面组,患者术后72 h的引流量及引流液中血红蛋白 浓度均较对照组明显减少(P<0.05);患者术后第1天腹腔引流液中血红蛋白浓度护固莱士组比泰绫组低(P<0.05);护固莱士组患者术后前3 d腹腔引流液中胆红素浓度比泰绫组、 对照组低(P<0.05)。结论 精准肝切除术肝创面的处理直接影响到患者术后恢复,泰绫能减少术后腹腔引流液量及出血量,而护固莱士不仅可减少术后腹腔引流量及出血量,还可 以减少胆汁漏量。
Abstract:
Objective To compare the hemostatic effect of fibringlue and tistat on hepatic cutting surface on human. Methods 60 patients with benign or malignant liver tumors who received precision liver resection surgery in 81 Hospital from September 2013 to October 2014 were enrolled in this study. According to the management of the hepatic cutting surface, the 60 patients were averagely divided into three groups: the fibringlue group, the tistat group and the control group. The drainage volume, hemoglobin and bilirubin in abdominal drainage, liver function after operation were determined and compared among the three groups. Results There were no significant differences among the three groups in age, gender, Child Pugh score, pathological type, tumor size, operative time, hemorrhage volume, wound area and postoperative recovery of liver function(P>0.05). The drainage volume and the hemoglobin in abdominal drainage of 72 hours after operation was significantly less in the fibringlue group and the tistat group than in the control group (P<0.05). Hemoglobin in the abdominal drainage fluid on postoperative day 1 were significantly lower in the fibringlue group than in the tistat group. Bilirubin of the abdominal drainage fluid in 72 hours after operation were significantly lower in the fibringlue group than in thetistat group and the control group (P<0.05). Conclusion The management of hepatic cutting surface will directly affect the patients’ postoperative recovery. Tistant can significantly reduce postoperative abdominal drainage volume and hemorrhage. Fibringlue can not only significantly reduce postoperative abdominal drainage volume and hemorrhage, but also the incidence of biliary leakage.

参考文献/References:

[1]李凌霏.肝脏可视化与精准肝切除的研究进展[J]. 重庆医学, 2013,42(10):1178-1180.
[2]王 伟,丁 伟,王 伯,等.精准肝切除治疗原发性肝癌临床效果的Meta分析[J].中国现代普通外科进展,2015,18(4):273-278.
[3]朱 迎,董 健,王万里.终末期肝病模型评分对评价肝癌患者肝切除围手术期风险的价值[J].中华肝胆外科杂志,2014,20(3):165-169.
[4]杜振双,赵利涛,何 谦,等. 快速康复外科理念在肝癌切除术中的应用[J]. 东南国防医药, 2013, 15(6):588-591.
[5]尹 涛,段传谊,符常波,等. 肝切除术创面不同处理方法效果的临床研究[J]. 腹部外科,2011,12(4):237-239.
[6]王平瑜,白雪峰,王保卫,等.人护固莱士对人肝损伤的止血护创作用[J].中国医学创新,2011,8(6):9-11.
[7]吴秀文 任建安. 纤维蛋白胶的外科应用[J]. 中华外科杂志, 2014,52(1):63-65.
[8]张少锋,洪加源.医用生物可吸收止血材料的研究现状与临床应用[J].中国组织工程研究,2012,16(21):3941-3944.
[9]王上忠,张培军,陈 剑,等. 肝内胆管结石合并肝门部胆管狭窄的手术处理分析[J]. 东南国防医药, 2006,8(5):350-352.
[10]程 翔,李 科,吴雨哲. 肝切除术后胆漏危险因素的多元回归分析[J].中华普通外科杂志, 2013,28(11):850-853.
[11]Sadamofi H,Yagi T,Shinoura S,et al.Risk factors for major morbidity after liver resection for hepatocellular carcinoma[J].Br J Surg,2013,100(1):122-129.
[12]姚汝铖. 肝切除安全性评估方法及临床应用的研究进展[J].医学研究生学报,2013,26(6):662-665.

相似文献/References:

备注/Memo

备注/Memo:
-
更新日期/Last Update: 2016-03-20